PATENT CLAIM ANALYSIS

Application Number: 15889459
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["424", "174100"]

Abstract:
The inventions describes a method for increasing effector T cell accumulation in cancer cell-containing sites of a tumor, comprising administering to a subject in need thereof a pharmaceutically effective amount of an inhibitor of CXCR4 signaling

Claim (Index 46):
The method of  claim 45 , wherein the carcinoma is selected from pancreatic carcinoma, melanoma, liver cancer, or lung carcinoma.

Metadata:
- Claim Count in Document: 134.0
- Percentile: 88.0
- Lexical Diversity: 1.19355
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15007002', '15748284', '14356996', '13806929', '15239524']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.698749049235116
- 35 USC 102 Novelty (BERT): 0.5250319769987271
- Combined Prediction Score: 0.6813773420114771
- Mean Citation Score: 282.8660700000001
- Max Citation Score: 288.41473
- Similarity Product: 182.3709999523712

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test